Amoxicillin: Clinical Overview
Amoxicillin is a broad-spectrum, acid-stable penicillin antibiotic that serves as first-line therapy for numerous bacterial infections due to its excellent oral bioavailability, safety profile, and activity against common respiratory and soft tissue pathogens.
Indications
Primary Indications (Adults and Pediatric Patients)
Amoxicillin is indicated for infections caused by susceptible organisms in the following conditions 1:
- Upper respiratory tract infections (ear, nose, throat)
- Lower respiratory tract infections (community-acquired pneumonia, bronchitis)
- Genitourinary tract infections (uncomplicated UTIs)
- Skin and soft tissue infections
Specific Clinical Applications
Community-Acquired Pneumonia (CAP):
- Preferred oral agent for mild-to-moderate CAP in children and adults 2
- Pediatric dosing: 50-75 mg/kg/day in 2 doses 2
- Adult dosing: 500 mg three times daily 3
Acute Otitis Media and Sinusitis:
- Standard dose: 45 mg/kg/day for mild disease without recent antibiotic exposure 4
- High-dose regimen (90 mg/kg/day) is preferred for moderate disease, recent antibiotic use (within 4-6 weeks), or areas with high penicillin-resistant S. pneumoniae prevalence 4
Skin and Soft Tissue Infections:
- Impetigo: 25 mg/kg/day of amoxicillin component (when combined with clavulanate) in 2 divided doses 5
- Effective against Staphylococcus and Streptococcus species when β-lactamase production is not a concern 5
Lyme Disease:
- Adults: 500 mg three times daily 3
- Children: 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) 3
- Duration: typically 14-21 days for early localized disease
Severe Acute Malnutrition (Uncomplicated):
- Oral amoxicillin is the preferred agent 6
- Dosing varies from 50-100 mg/kg/day depending on guideline source
Febrile Infants (29-60 days):
- For urinary tract infections: Ceftriaxone 50 mg/kg/dose every 24 hours is preferred, but oral cephalexin or cefixime may be used in infants >28 days 7
Adult-Only Indication
Helicobacter pylori infection and duodenal ulcer disease 1:
- Triple therapy: 1 gram amoxicillin + 500 mg clarithromycin + 30 mg lansoprazole, all twice daily for 14 days
- Dual therapy: 1 gram amoxicillin + 30 mg lansoprazole, three times daily for 14 days
Dosing Regimens
Standard Dosing
Adults:
- Range: 750-1750 mg/day in divided doses every 8-12 hours 1
- Typical dose: 500 mg three times daily or 875 mg twice daily
- Maximum: 4 grams/day for high-dose regimens 4
Pediatric Patients (>3 months):
- Range: 20-45 mg/kg/day in divided doses every 8-12 hours 1
- Standard dose: 40-45 mg/kg/day
- High-dose: 90 mg/kg/day (for resistant organisms or moderate-to-severe infections) 4
Neonates and Infants (≤3 months):
- Maximum: 30 mg/kg/day divided every 12 hours 1
Duration of Therapy
Short-course therapy is increasingly supported by evidence:
- CAP in children: 5 days of amoxicillin is non-inferior to 10 days 8
- Uncomplicated infections: 3-5 day courses may be adequate for select conditions 8
Renal Dosing Adjustments
Reduce dose in severe renal impairment (GFR <30 mL/min) 1. Specific adjustments should be based on creatinine clearance and severity of infection.
Amoxicillin vs. Amoxicillin-Clavulanate
Use amoxicillin alone whenever possible to minimize adverse effects and preserve the effectiveness of β-lactamase inhibitors 9.
Amoxicillin-clavulanate is indicated when:
- β-lactamase-producing organisms are suspected (H. influenzae, M. catarrhalis, S. aureus)
- Recent antibiotic failure with amoxicillin alone
- Moderate-to-severe infections requiring broader coverage 4
High-dose amoxicillin-clavulanate formulations:
- Adults: 4 g amoxicillin + 250 mg clavulanate daily 4
- Children: 90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate in 2 divided doses 4
- The 14:1 ratio (pediatric) minimizes clavulanate-related diarrhea 4
Contraindications
Absolute contraindications 1:
- History of serious hypersensitivity reactions (anaphylaxis, Stevens-Johnson syndrome) to amoxicillin or other β-lactams (penicillins, cephalosporins)
Relative contraindications:
- Infectious mononucleosis (high risk of erythematous rash) 1
- Severe renal impairment without dose adjustment
Common Side Effects
Most Common (>1%) 1
- Diarrhea (particularly with amoxicillin-clavulanate: 7-8% in clinical trials)
- Rash (non-allergic maculopapular rash common)
- Vomiting
- Nausea
Serious Adverse Events 1
Hypersensitivity reactions:
- Anaphylaxis (rare but potentially fatal)
- Serum sickness-like reactions
- Hypersensitivity vasculitis
Severe cutaneous adverse reactions (SCAR):
- Stevens-Johnson syndrome (SJS)
- Toxic epidermal necrolysis (TEN)
- Drug reaction with eosinophilia and systemic symptoms (DRESS)
- Acute generalized exanthematous pustulosis (AGEP)
- Monitor closely and discontinue if rash progresses 1
Clostridioides difficile-associated diarrhea (CDAD):
- Can range from mild diarrhea to fatal colitis
- May occur up to 2 months after antibiotic discontinuation 1
- Higher risk with amoxicillin-clavulanate than amoxicillin alone 10
Other notable adverse effects:
- Mucocutaneous candidiasis (Number Needed to Harm: 27 for amoxicillin with or without clavulanate) 10
- Hepatic dysfunction (cholestatic jaundice, hepatitis)
- Crystalluria (rare)
- Tooth discoloration (primarily in children; reversible with dental cleaning) 1
- Hematologic abnormalities (hemolytic anemia, thrombocytopenia—usually reversible)
Quantified Harm Data
From systematic review of placebo-controlled trials 10:
- Diarrhea with amoxicillin-clavulanate: Odds ratio 3.30 (95% CI 2.23-4.87); Number Needed to Harm = 10
- Candidiasis: Odds ratio 7.77 (95% CI 2.23-27.11); Number Needed to Harm = 27
- Rashes, nausea, vomiting, and abnormal liver function tests were not significantly increased compared to placebo
Important Drug Interactions 1
Probenecid:
- Decreases renal tubular secretion of amoxicillin
- Results in increased and prolonged blood levels
- Coadministration not recommended 1
Oral anticoagulants:
- May increase prothrombin time prolongation
- Monitor INR closely 1
Allopurinol:
- Increases risk of rash
- Use with caution 1
Oral contraceptives:
- May reduce efficacy
- Advise backup contraception 1
Clinical Pearls and Pitfalls
Pharmacokinetic advantages:
- Amoxicillin has twice the oral bioavailability of ampicillin, allowing for lower doses with equivalent efficacy 11
- Absorption is not affected by food, unlike many other antibiotics 9
- Serum levels increase linearly with dose—no absorption ceiling 4
Resistance considerations:
- Amoxicillin is the most active oral β-lactam against S. pneumoniae, including penicillin-resistant strains when high-dose regimens are used 4
- High-dose amoxicillin (90 mg/kg/day in children, 4 g/day in adults) overcomes relative penicillin resistance 4
- First-generation cephalosporins (e.g., cephalexin) are inactive against B. burgdorferi and should not be used for Lyme disease 3
Common prescribing errors to avoid:
- Using amoxicillin-clavulanate when amoxicillin alone would suffice (increases adverse effects without added benefit) 9
- Underdosing in moderate-to-severe infections or areas with resistant organisms 4
- Prescribing for viral infections or mononucleosis 1
- Failing to adjust dose in renal impairment 1
Antimicrobial stewardship: